These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 34358397

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals.
    Suppli MP, Rigbolt KTG, Veidal SS, Heebøll S, Eriksen PL, Demant M, Bagger JI, Nielsen JC, Oró D, Thrane SW, Lund A, Strandberg C, Kønig MJ, Vilsbøll T, Vrang N, Thomsen KL, Grønbæk H, Jelsing J, Hansen HH, Knop FK.
    Am J Physiol Gastrointest Liver Physiol; 2019 Apr 01; 316(4):G462-G472. PubMed ID: 30653341
    [Abstract] [Full Text] [Related]

  • 4. Bile Acids and Dysbiosis in Non-Alcoholic Fatty Liver Disease.
    Mouzaki M, Wang AY, Bandsma R, Comelli EM, Arendt BM, Zhang L, Fung S, Fischer SE, McGilvray IG, Allard JP.
    PLoS One; 2016 Apr 01; 11(5):e0151829. PubMed ID: 27203081
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Bile acids profile, histopathological indices and genetic variants for non-alcoholic fatty liver disease progression.
    Nimer N, Choucair I, Wang Z, Nemet I, Li L, Gukasyan J, Weeks TL, Alkhouri N, Zein N, Tang WHW, Fischbach MA, Brown JM, Allayee H, Dasarathy S, Gogonea V, Hazen SL.
    Metabolism; 2021 Mar 01; 116():154457. PubMed ID: 33275980
    [Abstract] [Full Text] [Related]

  • 7. Circulating lipidomic alterations in obese and non-obese subjects with non-alcoholic fatty liver disease.
    Jung Y, Lee MK, Puri P, Koo BK, Joo SK, Jang SY, Lee DH, Jung YJ, Kim BG, Lee KL, Park TS, Kang KT, Ryu DH, Kang SW, Kim D, Oh S, Kim W, Hwang GS.
    Aliment Pharmacol Ther; 2020 Nov 01; 52(10):1603-1614. PubMed ID: 32892365
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Ectodysplasin A Is Increased in Non-Alcoholic Fatty Liver Disease, But Is Not Associated With Type 2 Diabetes.
    Bayliss J, Ooi GJ, De Nardo W, Shah YJH, Montgomery MK, McLean C, Kemp W, Roberts SK, Brown WA, Burton PR, Watt MJ.
    Front Endocrinol (Lausanne); 2021 Nov 01; 12():642432. PubMed ID: 33746906
    [Abstract] [Full Text] [Related]

  • 10. Circulating Bile Acids as Biomarkers for Disease Diagnosis and Prevention.
    Qi L, Chen Y.
    J Clin Endocrinol Metab; 2023 Jan 17; 108(2):251-270. PubMed ID: 36374935
    [Abstract] [Full Text] [Related]

  • 11. Pegbelfermin selectively reduces secondary bile acid concentrations in patients with non-alcoholic steatohepatitis.
    Luo Y, Decato BE, Charles ED, Shevell DE, McNaney C, Shipkova P, Apfel A, Tirucherai GS, Sanyal AJ.
    JHEP Rep; 2022 Jan 17; 4(1):100392. PubMed ID: 34977519
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Irisin in patients with nonalcoholic fatty liver disease.
    Polyzos SA, Kountouras J, Anastasilakis AD, Geladari EV, Mantzoros CS.
    Metabolism; 2014 Feb 17; 63(2):207-17. PubMed ID: 24140091
    [Abstract] [Full Text] [Related]

  • 15. Clinical, anthropometric, biochemical, and histological characteristics of nonobese nonalcoholic fatty liver disease patients of Bangladesh.
    Alam S, Gupta UD, Alam M, Kabir J, Chowdhury ZR, Alam AK.
    Indian J Gastroenterol; 2014 Sep 17; 33(5):452-7. PubMed ID: 25023045
    [Abstract] [Full Text] [Related]

  • 16. Serum bile acid patterns are associated with the presence of NAFLD in twins, and dose-dependent changes with increase in fibrosis stage in patients with biopsy-proven NAFLD.
    Caussy C, Hsu C, Singh S, Bassirian S, Kolar J, Faulkner C, Sinha N, Bettencourt R, Gara N, Valasek MA, Schnabl B, Richards L, Brenner DA, Hofmann AF, Loomba R.
    Aliment Pharmacol Ther; 2019 Jan 17; 49(2):183-193. PubMed ID: 30506692
    [Abstract] [Full Text] [Related]

  • 17. Natural History of Non-Alcoholic Fatty Liver Disease: A Study With Paired Liver Biopsies.
    Reddy YK, Marella HK, Jiang Y, Ganguli S, Snell P, Podila PSB, Maliakkal B, Satapathy SK.
    J Clin Exp Hepatol; 2020 Jan 17; 10(3):245-254. PubMed ID: 32405181
    [Abstract] [Full Text] [Related]

  • 18. Free fatty acids repress small heterodimer partner (SHP) activation and adiponectin counteracts bile acid-induced liver injury in superobese patients with nonalcoholic steatohepatitis.
    Bechmann LP, Kocabayoglu P, Sowa JP, Sydor S, Best J, Schlattjan M, Beilfuss A, Schmitt J, Hannivoort RA, Kilicarslan A, Rust C, Berr F, Tschopp O, Gerken G, Friedman SL, Geier A, Canbay A.
    Hepatology; 2013 Apr 17; 57(4):1394-406. PubMed ID: 23299969
    [Abstract] [Full Text] [Related]

  • 19. LC-MS-based lipidomic analysis in distinguishing patients with nonalcoholic steatohepatitis from nonalcoholic fatty liver.
    Wang ZH, Zheng KI, Wang XD, Qiao J, Li YY, Zhang L, Zheng MH, Wu J.
    Hepatobiliary Pancreat Dis Int; 2021 Oct 17; 20(5):452-459. PubMed ID: 34256994
    [Abstract] [Full Text] [Related]

  • 20. Growing burden of nonalcoholic fatty liver disease in Turkey: A single-center experience.
    Yılmaz Y, Kanı HT, Demirtaş CÖ, Kaya E, Sapmaz AF, Qutranji L, Alkayyali T, Batun KD, Batman M, Toy B, Çiftaslan A.
    Turk J Gastroenterol; 2019 Oct 17; 30(10):892-898. PubMed ID: 31258138
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.